Peplomycin and bleomycin effects on human colon cancer cells.
The lethal effects of peplomycin and bleomycin on cultured human colon cancer cells (LoVo) were compared by using the technique of inhibition of colony formation. The survival of LoVo cells after treatment for 1 h with either peplomycin or bleomycin was characterized by a biphasic exponential curve. When the exposure time was extended to 24 h, both drugs produced much greater cytotoxic effects, with survival decreased to less than 0.10% for bleomycin and less than 0.02% for peplomycin. Both peplomycin and bleomycin, in a dose-dependent manner, inhibited the incorporation of thymidine into cells. On an equal-weight basis, the cytotoxicity of peplomycin (24-h exposure) was similar to that of bleomycin. Both agent also inhibited the incorporation of leucine and uridine after 24 h of drug exposure, but to a lesser extent than inhibition of thymidine incorporation. However, after 1 h of exposure, such inhibitory effects were minimal. These results demonstrate that prolonged peplomycin or bleomycin exposure produces greater cell-kill than shorter drug exposure. Schedules with continuous drug administration should be explored clinically.
A
A
Uematsu
D H
DH
Ho
B
B
Drewinko
L Y
LY
Yang
N S
NS
Brown
G P
GP
Bodey
I H
IH
Krakoff
D001761:Bleomycin / Q000627:therapeutic use*; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D003110:Colonic Neoplasms / Q000188:drug therapy*; D003114:Colony-Forming Units Assay; D006801:Humans; D007930:Leucine / Q000378:metabolism; D017663:Peplomycin; D013936:Thymidine / Q000378:metabolism; D014529:Uridine / Q000378:metabolism
D001761:Bleomycin; D017663:Peplomycin; D007930:Leucine; D013936:Thymidine; D014529:Uridine